Artículos de revistas
Umbelliferone Induces Changes In The Structure And Pharmacological Activities Of Bn Iv, A Phospholipase A2 Isoform Isolated From Bothrops Neuwiedi
Registro en:
Toxicon. , v. 57, n. 6, p. 851 - 860, 2011.
410101
10.1016/j.toxicon.2011.02.024
2-s2.0-79954995046
Autor
Toyama D.D.O.
Diz Filho E.B.D.S.
Cavada B.S.
da Rocha B.A.M.
de Oliveira S.C.B.
Cotrim C.A.
Soares V.C.G.
Delatorre P.
Marangoni S.
Toyama M.H.
Institución
Resumen
In this paper was demonstrated that umbelliferone induces changes in structure and pharmacological activities of Bn IV, a lysine 49 secretory phospholipase A2 (sPLA2) from Bothrops neuwiedi. Incubation of Bn IV with umbelliferone virtually abolished platelet aggregation, edema, and myotoxicity induced by native Bn IV. The amino acid sequence of Bn IV showed high sequence similarities with other Lys49 sPLA2s from B. jararacussu (BthTx-I), B. pirajai (PrTx-I), and B. neuwiedi pauloensis (Bn SP6 and Bn SP7). This sPLA2 also has a highly conserved C-terminal amino acid sequence, which has been shown as important for the pharmacological activities of Lys49 sPLA2. Sequencing of Bn IV previously treated with umbelliferone revealed modification of S(1) and S(20). Fluorescent spectral analysis and circular dichroism (CD) studies showed that umbelliferone modified the secondary structure of this protein. Moreover, the pharmacological activity of Bn IV is driven by synergism of the C-terminal region with the α-helix motifs, which are involved in substrate binding of the Asp49 and Lys49 residues of sPLA2 and have a direct effect on the Ca2+-independent membrane damage of some secretory snake venom PLA2. For Bn IV, these interactions are potentially important for triggering the pharmacological activity of this sPLA2. © 2011 Elsevier Ltd. 57 6 851 860 Chan, A.C., Pritchard, E.T., Gerrard, J.M., Man, R.Y., Choy, P.C., Biphasic modulation of platelet phospholipase A2 activity and platelet aggregation by mepacrine (quinacrine) (1982) Biochim. Biophys. Acta., 713 (1), pp. 170-172 Chioato, L., Ward, R.J., Mapping structural determinants of biological activities in snake venom phospholipases A2 by sequence analysis and site directed mutagenesis (2003) Toxicon, 42 (8), pp. 869-883 Chioato, L., Aragão, E.A., Lopes Ferreira, T., Medeiros, A.I., Faccioli, L.H., Ward, R.J., Mapping of the structural determinants of artificial and biological membrane damaging activities of a Lys49 phospholipase A2 by scanning alanine mutagenesis (2007) Biochim. Biophys. Acta., 1768 (5), pp. 1247-1257 Cintra, A.C., Marangoni, S., Oliveira, B., Giglio, J.R., Bothropstoxin-I: amino acid sequence and function (1993) J. Protein Chem., 12 (1), pp. 57-64 Di Carlo, G., Mascolo, N., Izzo, A.A., Capasso, F., Flavonoids: old and new aspects of a class of natural therapeutic drugs (1999) Life Sci., 65, pp. 337-353 dos Santos, M.L., Fagundes, F.H., Teixeira, B.R., Toyama, M.H., Aparicio, R., Purification and preliminary crystallographic analysis of a new Lys49-PLA2 from B. Jararacussu (2008) Int. J. Mol. Sci., 9 (5), pp. 736-750 Diz Filho, E.B., Marangoni, S., Toyama, D.O., Fagundes, F.H., Oliveira, S.C., Fonseca, F.V., Calgarotto, A.K., Toyama, M.H., Enzymatic and structural characterization of new PLA2 isoform isolated from white venom of Crotalus durissus ruruima (2009) Toxicon, 53 (1), pp. 104-114 Fawzy, A.A., Vishwanath, B.S., Franson, R.C., Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action (1988) Agents Actions, 25, pp. 394-400 Fonseca, F.V., Baldissera, L., Camargo, E.A., Antunes, E., Diz-Filho, E.B., Corrêa, A.G., Beriam, L.O., Toyama, M.H., Effect of the synthetic coumarin, ethyl 2-oxo-2H-chromene-3-carboxylate, on activity of Crotalus durissus ruruima sPLA2 as well as on edema and platelet aggregation induced by this factor (2010) Toxicon, 55 (8), pp. 1527-1530. , J Fuly, A.L., Soares, A.M., Marcussi, S., Giglio, J.R., Guimar̃aes, J.A., Signal transduction pathways involved in the platelet aggregation induced by a D-49 phospholipase A2 isolated from Bothrops jararacussu snake venom (2004) Biochimie, 86, pp. 731-739 Gil, B., Sanz, M.J., Terencio, M.C., Gunasegaran, R., Payá, M., Alcaraz, M.J., Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity (1997) Biochem Pharmacol., 53 (5), pp. 733-740 Ghani, U., Ng, K.K., Atta-ur-Rahman Choudhary, M.I., Ullah, N., James, M.N., Crystal structure of gamma-chymotrypsin in complex with 7-hydroxycoumarin (2001) J Mol Biol., 314 (3), pp. 519-525 Gutiérrez, J.M., Ownby, C.L., Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity (2003) Toxicon, 42 (8), pp. 915-931 Hefner, Y., Borsch-Haubold, A.G., Murakami, M., Wilde, J.I., Pasquet, S., Schieltz, D., Ghomashchi, F., Gelb, M.H., Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases (2000) J. Biol. Chem., 275 (48), pp. 37542-37551 Henrikson, R.L., Meredith, S.C., Amino acid analysis by reverse phase high performance liquid chromatography: pre-column derivatization with phenylisothiocyanate (1984) Anal. Biochem., 136, pp. 65-71 Holland, J.A., Pritchard, K.A., Pappolla, M.A., Wolin, M.S., Rogers, N.J., Stemerman, M.B., Bradykinin induces superoxide anion release from human endothelial cells (1990) J. Cell Physiol., 143 (1), pp. 21-25 Iglesias, C.V., Aparicio, R., Rodrigues-Simioni, L., Camargo, E.A., Antunes, E., Marangoni, S., Toyama, D.O., Toyama, M.H., Effects of morin on snake venom phospholipase A(2) (PLA(2) (2005) Toxicon, 46, pp. 751-758 Kostova, I., Monolov, I., Karaivonova, M., Synthesis, physicochemical characterization, and cytotoxic screening of new zirconium complexes with coumarin derivatives (2001) Arch. Pharm. (Weinheim), 334, pp. 157-162 Kramer, R.M., Roberts, E.F., Manetta, J.V., Hyslop, P.A., Jakubowski, J.A., Thrombin-induced phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in human platelets (1993) J. Biol. Chem., 268, pp. 26796-26804 Kramer, R.M., Roberts, E.F., Um, S.L., Börsch-Haubold, A.G., Watson, S.P., Fisher, M.J., Jakubowski, J.A., P38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2 (1996) J. Biol. Chem., 271 (44), pp. 27723-27729 Kroll, M.H., Schafer, A.I., Biochemical mechanisms of platelet activation (1989) Blood, 74 (4), pp. 1181-1195 Leung, L., Nachman, R., Molecular mechanisms of platelet aggregation (1986) Annu. Rev. Med., 37, pp. 179-186 Lindahl, M., Tagesson, C., Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2 (1997) Inflammation, 21, pp. 347-356 Lomonte, B., Angulo, Y., Calderón, L., An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action (2003) Toxicon, 42 (8), pp. 885-901 Magro, A.J., Soares, A.M., Giglio, J.R., Fontes, M.R., Crystal structures of BnSP-7 and BnSP-6, two Lys49-phospholipases A(2): quaternary structure and inhibition mechanism insights (2003) Biochem. Biophys. Res. Comm., 311 (3), pp. 713-720 Marshall, L.A., Chang, J.Y., Calhoun, W., Yu, J., Carlson, R.P., Preliminary studies on phospholipase A2-induced mouse paw edema as a model to evaluate antiinflammatory agents (1989) J. Cell Biochem., 40 (2), pp. 147-155 Massini, P., Lüscher, E.F., On the significance of the influx of calcium ions into stimulated human blood platelets (1976) Biochim Biophys Acta., 436 (3), pp. 652-663 Murray, R.D., Coumarins (1989) Nat. Prod. Rep., 6, pp. 591-624 Nirmal, N., Praba, G.O., Velmurugan, D., Modeling studies on phospholipase A2-inhibitor complexes (2008) Indian J. Biochem. Biophys., 45 (4), pp. 256-262 Oliveira, C.F., Lopes, D.S., Mendes, M.M., Homsi-Brandeburgo, M.I., Hamaguchi, A., de Alcântara, T.M., Clissa, P.B., Rodrigues, V.M., Insights of local tissue damage and regeneration induced by BnSP-7, a myotoxin isolated from Bothrops (neuwiedi) pauloensis snake venom (2009) Toxicon, 53 (5), pp. 560-569 Polgár, J., Kramer, R.M., Um, S.L., Jakubowski, J.A., Clemetson, K.J., Human group II 14 kDa phospholipase A2 activates human platelets (1997) Biochem. J, 327 (PART 1), pp. 259-265 Puri, R.N., Phospholipase A2: its role in ADP- and thrombin-induced platelet activation mechanisms (1998) Int. J. Biochem. Cell Biol., 30, pp. 1107-1122 Qin, S., Pande, A.H., Nemec, K.N., Tatulian, S.A., The N-terminal alpha-helix of pancreatic phospholipase A2 determines productive-mode orientation of the enzyme at the membrane surface (2004) J. Mol. Biol., 344 (1), pp. 71-89 Qin, S., Pande, A.H., Nemec, K.N., He, X., Tatulian, S.A., Evidence for the regulatory role of the N-terminal helix of secretory phospholipase A(2) from studies on native and chimeric proteins (2005) J. Biol. Chem., 280 (44), pp. 36773-36783 Rotelli, A.E., Guardia, T., Juárez, A.O., de la Rocha, N.E., Pelzer, L.E., Comparative study of flavonoids in experimental models of inflammation (2003) Pharmacol. Res., 48, pp. 601-606 Schagger, H., von Jagow, G., Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa (1987) Anal. Biochem., 1, pp. 368-379 Soares, A.M., Andrião-Escarso, S.H., Bortoleto, R.K., Rodrigues-Simioni, L., Arni, R.K., Ward, R.J., Gutiérrez, J.M., Giglio, J.R., Dissociation of enzymatic and pharmacological properties of piratoxins-I and -III, two myotoxic phospholipases A2 from Bothrops pirajai snake venom (2001) Arch. Biochem. Biophys., 387 (2), pp. 188-196 Toyama, M.H., Soares, A.M., Vieira, C.A., Novello, J.C., Oliveira, B., Giglio, J.R., Marangoni, S., Amino acid sequence of piratoxin-I, a myotoxin from Bothrops pirajai snake venom, and its biological activity after alkylation with p-bromophenacyl bromide (1998) J. Protein Chem., 17 (7), pp. 713-718 Toyama, M.H., Carneiro, E.M., Marangoni, S., Barbosa, R.L., Corso, G., Boschero, A.C., Biochemical characterization of two crotamine isoforms isolated by a single step RP-HPLC from Crotalus durissus terrificus (South American rattlesnake) venom and their action on insulin secretion by pancreatic islets (2000) Biochim. Biophys. Acta, 1474, pp. 56-60 Toyama, M.H., Soares, A.M., Wen-Hwa, L., Polikarpov, I., Giglio, J.R., Marangoni, S., Amino acid sequence of piratoxin-II, a myotoxic lys49 phospholipase A(2) homologue from Bothrops pirajai venom (2000) Biochimie, 82 (3), pp. 245-250 Toyama, M.H., de Oliveira, D.G., Beriam, L.O., Novello, J.C., Rodrigues-Simioni, L., Marangoni, S., Structural, enzymatic and biological properties of new PLA(2) isoform from Crotalus durissus terrificus venom (2003) Toxicon, 41, pp. 1033-1038 Toyama, M.H., Toyama, D.O., Joazeiro, P.P., Carneiro, E.M., Beriam, L.O.S., Marangoni, S., Boschero, A.C., Biological and structural characterization of a new PLA(2) from the Crotalus durissus collilineatus venom (2005) Protein J., 24, pp. 103-112 Toyama, D.O., Marangoni, S., Diz-Filho, E.B., Oliveira, S.C., Toyama, M.H., Effect of umbelliferone (7-hydroxycoumarin, 7-HOC) on the enzymatic, edematogenic and necrotic activities of secretory phospholipase A2 (sPLA2) isolated from Crotalus durissus collilineatus venom (2009) Toxicon, 53 (4), pp. 417-426 Vincent, J.E., Zijlstra, F.J., Biphasic effects of phospholipase A2 on platelet aggregation. Effect of prostaglandin synthesis inhibitors and essential fatty acid deficiency (1976) Prostaglandins, 12 (6), pp. 971-979 Vishwanath, B.S., Fawzy, A.A., Franson, R.C., Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid (1988) Inflammation, 12, pp. 549-561